Compound information
- Natural Products
- ZC548330
- Molecular Formula
- C18H27N3O4S
- Molecular Weight
- 381.172227344 g/mol
- Structure
-
- IUPAC Name
- benzyl (3R)-3-[(1-methyl-4-piperidyl)sulfamoyl]pyrrolidine-1-carboxylate
- InChI
- InChI=1S/C18H27N3O4S/c1-20-10-7-16(8-11-20)19-26(23,24)17-9-12-21(13-17)18(22)25-14-15-5-3-2-4-6-15/h2-6,16-17,19H,7-14H2,1H3/t17-/m1/s1
- InChI Key
- CUVPYANXQACRMQ-QGZVFWFLSA-N
- SMILES
- CN1CCC(NS(=O)(=O)[C@@H]2CCN(C(=O)OCc3ccccc3)C2)CC1
- Source
- ZINC000253427017
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 78.95 Å2 | LogP | 1.518 |
LogS | -1.796 | LogD | 1.344 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.069 | Pgp substrate | 0.985 |
HIA | 0.968 | F20 % | 0.965 |
F30 % | 0.606 | Caco-2 | -4.955 |
MDCK | -5.135 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.014 | PPB | 35.259 |
VD | 1.811 | Fu | 0.017 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.072 | CYP1A2 substrate | 0.649 |
CYP2A6 substrate | 0.455 | CYP2B6 substrate | 0.636 |
CYP2C19 inhibitor | 0.054 | CYP2C19 substrate | 0.831 |
CYP2C8 substrate | 0.651 | CYP2C9 inhibitor | 0.024 |
CYP2C9 substrate | 0.997 | CYP2D6 inhibitor | 0.055 |
CYP2D6 substrate | 0.923 | CYP2E1 substrate | 0.135 |
CYP3A4 inhibitor | 0.02 | CYP3A4 substrate | 0.994 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.516 | CL | 3.885 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.004 | Hepatotoxicity | 0.929 |
Mutagenicity | 0.026 | Rat Oral Acute Toxicity | 0.65 |
FDAMDD | 0.699 | Skin Sensitization | 0.812 |
Carcinogenicity | 0.021 | Eye Corrosion | 0.004 |
Eye Irritation | 0.003 | Respiratory Toxicity | 0.941 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.404 | IGC50 | 2.337 |
LC50FM | -0.561 | LC50DM | -3.675 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.707 | NR-AR-LBD | 0.263 |
NR-AhR | 0.006 | NR-Aromatase | 0.017 |
NR-ER | 0.345 | NR-ER-LBD | 0.293 |
NR-PPAR-gamma | 0.092 | SR-ARE | 0.036 |
SR-ATAD5 | 0.245 | SR-HSE | 0.113 |
SR-MMP | 0.011 | SR-p53 | 0.058 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.